Suppr超能文献

肝手术中术中血管阻断对长期结局的影响:系统评价和荟萃分析。

Impact of intraoperative vascular occlusion during liver surgery on long-term outcomes: A systematic review and meta-analysis.

机构信息

Department of General Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, PR China.

Department of General Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, PR China.

出版信息

Int J Surg. 2017 Aug;44:110-116. doi: 10.1016/j.ijsu.2017.06.050. Epub 2017 Jun 20.

Abstract

OBJECTIVE

To determine the impact of intraoperative vascular occlusion during liver surgery on postoperative long-term outcomes for hepatocellular carcinoma (HCC) patients using a meta-analysis.

METHODS

A systematic literature search of PubMed, EMBASE, and Cochrane Central was conducted to discover relevant randomized controlled trials (RCTs) and observational studies. Studies that reported postoperative long-term outcomes; 1-, 3-, and 5-year overall survival (OS); and/or 1-, 3-, and 5-year recurrence-free survival (RFS) for both an observation group (vascular occlusion) and a control group (vascular non-occlusion) were included. Forest plots were performed to calculate the difference between the 2 groups. The Q statistic and the I index statistic were used to assess heterogeneity. Publication bias was evaluated using Egger's test.

RESULTS

Four observational studies containing 2917 patients were included in this meta-analysis. The pooled estimation results indicated that intraoperative vascular occlusion would not shorten the postoperative OS (RR = 1.01; 95%CI: 0.98-1.03; P = 0.763) and would not increase the risk of HCC recurrence (RR = 0.99; 95%CI: 0.97-1.02; P = 0.320) with low heterogeneity (I = 0.0% and 12.7%, respectively). Furthermore, Egger's test did not reveal any publication bias (P = 0.405 and P = 0.269, respectively) in this research.

CONCLUSIONS

Intraoperative vascular occlusion during liver surgery is safe for HCC patients. It does not affect the postoperative overall survival or increase the risk of HCC recurrence.

摘要

目的

通过荟萃分析,确定肝外科手术中术中血管阻断对肝细胞癌(HCC)患者术后长期结局的影响。

方法

对 PubMed、EMBASE 和 Cochrane Central 进行系统文献检索,以发现相关的随机对照试验(RCT)和观察性研究。纳入报告观察组(血管阻断)和对照组(血管非阻断)术后长期结局、1 年、3 年和 5 年总生存率(OS)和/或 1 年、3 年和 5 年无复发生存率(RFS)的研究。采用森林图计算两组间的差异。采用 Q 统计量和 I 指数统计量评估异质性。采用 Egger 检验评估发表偏倚。

结果

该荟萃分析纳入了 4 项包含 2917 例患者的观察性研究。汇总估计结果表明,术中血管阻断不会缩短术后 OS(RR=1.01;95%CI:0.98-1.03;P=0.763),也不会增加 HCC 复发的风险(RR=0.99;95%CI:0.97-1.02;P=0.320),异质性较低(I=0.0%和 12.7%)。此外,Egger 检验未发现本研究存在任何发表偏倚(P=0.405 和 P=0.269)。

结论

肝外科手术中术中血管阻断对 HCC 患者是安全的。它不会影响术后总体生存率或增加 HCC 复发的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验